Characterization of human FOXP1 isoform 2, using monoclonal antibody 4E3‐G11, and intron retention as a tissue‐specific mechanism generating a novel FOXP1 isoform
- 25 February 2008
- journal article
- Published by Wiley in Histopathology
- Vol. 52 (5) , 632-637
- https://doi.org/10.1111/j.1365-2559.2008.02990.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- FOXP1: a potential therapeutic target in cancerEmerging Therapeutic Targets, 2007
- Sequence features responsible for intron retention in humanBMC Genomics, 2007
- Foxp1 is an essential transcriptional regulator of B cell developmentNature Immunology, 2006
- Identification of Potential Human Oncogenes by Mapping the Common Viral Integration Sites in Avian NephroblastomaCancer Research, 2006
- Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell LymphomaClinical Cancer Research, 2005
- Foxp1regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturationDevelopment, 2004
- Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast CarcinomasClinical Cancer Research, 2004
- Characterization of a New Subfamily of Winged-helix/Forkhead (Fox) Genes That Are Expressed in the Lung and Act as Transcriptional RepressorsJournal of Biological Chemistry, 2001